13.09.2004
Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation:
The Anticoagulation in Cardioversion using Enoxaparin (ACE) trial
C. Stellbrink, U. Nixdorff, T. Hofmann, W. Lehmacher, W.G. Daniel, P. Hanrath, C. Geller, A. Mügge, W. Sehnert, C. Schmidt-Lucke, J.-A. Schmidt-Lucke; on behalf of the ACE (Anticoagulation in Cardioversion using Enoxaparin) study group
Circulation, 2004; 109: 997-1003